A detailed history of Fny Investment Advisers, LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Fny Investment Advisers, LLC holds 24 shares of OCGN stock, worth $21. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24
Holding current value
$21
% of portfolio
0.0%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $195M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.